(OHI) Omega Healthcare Investors - Ratings and Ratios
Skilled Nursing, Assisted Living Facilities, Healthcare Properties
OHI EPS (Earnings per Share)
OHI Revenue
Description: OHI Omega Healthcare Investors
Omega Healthcare Investors Inc (NYSE:OHI) is a Real Estate Investment Trust (REIT) that provides financing to the long-term healthcare industry, focusing on skilled nursing and assisted living facilities in the US and UK. With a diverse portfolio of 978 operating facilities across 42 states, the District of Columbia, and the UK, Omega has established itself as a significant player in the healthcare REIT sector.
The companys investment strategy is centered around identifying high-quality healthcare properties with experienced operators that offer a favorable risk/reward ratio. As a major capital provider to the healthcare industry, Omega continually assesses industry trends, opportunities, and challenges to inform its investment decisions. Key performance indicators (KPIs) to monitor include occupancy rates, revenue growth, and operator quality, as well as metrics such as Funds From Operations (FFO) and Adjusted Funds From Operations (AFFO) to gauge the companys financial health and dividend sustainability.
From a financial perspective, Omegas REIT status allows it to pass through a significant portion of its income to shareholders, making dividend yield an important consideration. Key metrics to evaluate include the dividend yield, payout ratio, and debt-to-equity ratio. As a REIT, Omega is required to distribute at least 90% of its taxable income to shareholders, which can result in a relatively stable income stream for investors. With a market capitalization of $11.17 billion, Omega is a sizable player in the healthcare REIT space, and its financial performance is closely tied to the overall health of the long-term care industry.
To further analyze Omegas performance, its essential to examine its ability to generate cash flows, manage its debt, and maintain a strong balance sheet. Metrics such as interest coverage ratio, debt service coverage ratio, and cash flow per share can provide valuable insights into the companys financial stability and ability to meet its dividend obligations. By closely monitoring these KPIs, investors can gain a deeper understanding of Omegas investment potential and make more informed decisions.
OHI Stock Overview
| Market Cap in USD | 12,990m |
| Sub-Industry | Health Care REITs |
| IPO / Inception | 1992-08-07 |
OHI Stock Ratings
| Growth Rating | 59.9% |
| Fundamental | 67.3% |
| Dividend Rating | 62.2% |
| Return 12m vs S&P 500 | -5.67% |
| Analyst Rating | 3.69 of 5 |
OHI Dividends
| Dividend Yield 12m | 6.74% |
| Yield on Cost 5y | 12.42% |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 85.8% |
| Payout Ratio | 1.6% |
OHI Growth Ratios
| Growth Correlation 3m | 95.9% |
| Growth Correlation 12m | 8.3% |
| Growth Correlation 5y | 78.6% |
| CAGR 5y | 19.91% |
| CAGR/Max DD 3y | 1.03 |
| CAGR/Mean DD 3y | 3.31 |
| Sharpe Ratio 12m | 0.44 |
| Alpha | -6.28 |
| Beta | 0.968 |
| Volatility | 18.23% |
| Current Volume | 928.2k |
| Average Volume 20d | 1771k |
| Stop Loss | 41.4 (-3%) |
| Signal | 0.41 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (470.7m TTM) > 0 and > 6% of Revenue (6% = 66.9m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 0.61pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 219.5% (prev 165.9%; Δ 53.58pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 835.1m > Net Income 470.7m (YES >=105%, WARN >=100%) |
| Net Debt (4.27b) to EBITDA (1.02b) ratio: 4.17 <= 3.0 (WARN <= 3.5) |
| Current Ratio 7.85 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (303.2m) change vs 12m ago 15.95% (target <= -2.0% for YES) |
| Gross Margin 98.78% (prev 98.50%; Δ 0.28pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 11.49% (prev 11.05%; Δ 0.45pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.29 (EBITDA TTM 1.02b / Interest Expense TTM 215.1m) >= 6 (WARN >= 3) |
Altman Z'' 0.23
| (A) 0.23 = (Total Current Assets 2.80b - Total Current Liabilities 357.0m) / Total Assets 10.55b |
| (B) -0.34 = Retained Earnings (Balance) -3.57b / Total Assets 10.55b |
| (C) 0.07 = EBIT TTM 706.9m / Avg Total Assets 9.70b |
| (D) -0.64 = Book Value of Equity -3.44b / Total Liabilities 5.36b |
| Total Rating: 0.23 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 67.25
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 4.84% = 2.42 |
| 3. FCF Margin 74.92% = 7.50 |
| 4. Debt/Equity 1.00 = 2.02 |
| 5. Debt/Ebitda 4.89 = -2.50 |
| 6. ROIC - WACC 0.12% = 0.15 |
| 7. RoE 10.19% = 0.85 |
| 8. Rev. Trend 70.05% = 5.25 |
| 9. EPS Trend 61.15% = 3.06 |
What is the price of OHI shares?
Over the past week, the price has changed by -1.50%, over one month by +4.10%, over three months by +20.37% and over the past year by +12.15%.
Is Omega Healthcare Investors a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of OHI is around 46.08 USD . This means that OHI is currently overvalued and has a potential downside of 7.94%.
Is OHI a buy, sell or hold?
- Strong Buy: 4
- Buy: 3
- Hold: 9
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the OHI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 43.4 | 1.7% |
| Analysts Target Price | 43.4 | 1.7% |
| ValueRay Target Price | 50.8 | 19% |
Last update: 2025-09-12 04:42
OHI Fundamental Data Overview
CCE Cash And Equivalents = 734.2m USD (last quarter)
P/E Trailing = 26.4444
P/E Forward = 10.1317
P/S = 11.6536
P/B = 2.5329
P/EG = 1.13
Beta = 0.705
Revenue TTM = 1.11b USD
EBIT TTM = 706.9m USD
EBITDA TTM = 1.02b USD
Long Term Debt = 5.00b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (0.0)
Debt = 5.00b USD (Calculated: Short Term 0.0 + Long Term 5.00b)
Net Debt = 4.27b USD (from netDebt column, last quarter)
Enterprise Value = 17.26b USD (12.99b + Debt 5.00b - CCE 734.2m)
Interest Coverage Ratio = 3.29 (Ebit TTM 706.9m / Interest Expense TTM 215.1m)
FCF Yield = 4.84% (FCF TTM 835.1m / Enterprise Value 17.26b)
FCF Margin = 74.92% (FCF TTM 835.1m / Revenue TTM 1.11b)
Net Margin = 42.23% (Net Income TTM 470.7m / Revenue TTM 1.11b)
Gross Margin = 98.78% ((Revenue TTM 1.11b - Cost of Revenue TTM 13.6m) / Revenue TTM)
Tobins Q-Ratio = -5.01 (set to none) (Enterprise Value 17.26b / Book Value Of Equity -3.44b)
Interest Expense / Debt = 1.06% (Interest Expense 52.9m / Debt 5.00b)
Taxrate = 2.53% (10.9m / 428.7m)
NOPAT = 689.0m (EBIT 706.9m * (1 - 2.53%))
Current Ratio = 7.85 (Total Current Assets 2.80b / Total Current Liabilities 357.0m)
Debt / Equity = 1.00 (Debt 5.00b / last Quarter total Stockholder Equity 4.99b)
Debt / EBITDA = 4.89 (Net Debt 4.27b / EBITDA 1.02b)
Debt / FCF = 5.99 (Debt 5.00b / FCF TTM 835.1m)
Total Stockholder Equity = 4.62b (last 4 quarters mean)
RoA = 4.46% (Net Income 470.7m, Total Assets 10.55b )
RoE = 10.19% (Net Income TTM 470.7m / Total Stockholder Equity 4.62b)
RoCE = 7.35% (Ebit 706.9m / (Equity 4.62b + L.T.Debt 5.00b))
RoIC = 7.33% (NOPAT 689.0m / Invested Capital 9.40b)
WACC = 7.20% (E(12.99b)/V(17.99b) * Re(9.58%)) + (D(5.00b)/V(17.99b) * Rd(1.06%) * (1-Tc(0.03)))
Shares Correlation 3-Years: 93.94 | Cagr: 2.02%
Discount Rate = 9.58% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 73.76% ; FCFE base≈759.7m ; Y1≈800.8m ; Y5≈943.8m
Fair Price DCF = 42.97 (DCF Value 12.68b / Shares Outstanding 295.0m; 5y FCF grow 5.89% → 3.0% )
EPS Correlation: 61.15 | EPS CAGR: 5.64% | SUE: 1.17 | # QB: True
Revenue Correlation: 70.05 | Revenue CAGR: 6.20%
Additional Sources for OHI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle